Market Insights Health Pharmacies OTC Products

Analgesics (Pharmacies) - United States

United States

Revenue in the Analgesics market is projected to reach €4.19bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.69%, resulting in a market volume of €5.27bn by 2029.
In global comparison, most revenue will be generated in China (€4,663.00m in 2024).
In relation to total population figures, per person revenues of €12.26 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Analgesics (Pharmacies) market in United States has been experiencing significant growth in recent years.

Customer preferences: Customers in the United States have shown a strong preference for analgesics purchased from pharmacies. This can be attributed to the convenience and accessibility of pharmacies, as well as the trust that customers have in the quality and efficacy of the products sold in these establishments. Additionally, pharmacies often provide additional services such as consultations with pharmacists, which further enhance the customer experience.

Trends in the market: One of the key trends in the Analgesics (Pharmacies) market in United States is the increasing demand for over-the-counter (OTC) analgesics. This can be attributed to several factors, including the rising prevalence of chronic pain conditions, the aging population, and the growing awareness and acceptance of self-medication practices. OTC analgesics offer a convenient and cost-effective solution for individuals seeking relief from mild to moderate pain without the need for a prescription. Another trend in the market is the growing popularity of natural and herbal analgesics. Consumers in the United States are becoming more health-conscious and are seeking alternative treatment options that are perceived to be safer and have fewer side effects. As a result, there has been an increase in the demand for analgesics derived from natural sources such as plants and herbs.

Local special circumstances: The United States has a well-established healthcare system, which includes a large number of pharmacies across the country. These pharmacies serve as a primary point of access for individuals seeking healthcare products, including analgesics. The presence of a vast network of pharmacies ensures that customers have easy access to a wide range of analgesics, thereby driving market growth.

Underlying macroeconomic factors: The growing demand for analgesics in the United States can also be attributed to underlying macroeconomic factors. The country has a high prevalence of chronic pain conditions, such as arthritis and back pain, which drive the need for pain relief medications. Additionally, the aging population in the United States is increasing, leading to a higher demand for analgesics to manage age-related pain and discomfort. Furthermore, the United States has a high disposable income and a strong consumer culture, which enables individuals to afford and purchase analgesics. The availability of various payment options, such as insurance coverage and flexible spending accounts, further facilitates the purchase of analgesics. In conclusion, the Analgesics (Pharmacies) market in United States is experiencing growth due to customer preferences for pharmacy purchases, the increasing demand for OTC analgesics, the popularity of natural and herbal analgesics, the presence of a large number of pharmacies, the high prevalence of chronic pain conditions, the aging population, and the strong macroeconomic factors in the country.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.